Icon

DUOBRII (nda209354)- (0.01%;0.045%)

HALOBETASOL PROPIONATE; TAZAROTENE BAUSCH
0.01%;0.045%
Yes No
2036-Jun-06 Expired
None 2022-Apr-25
None No
DUOBRII Lotion is a combination of halobetasol propionate and tazarotene indicated for the topical treatment of plaque psoriasis in adults.
0 1 0
Total Other Developers 7
Drugs with Suitability No
0.01%;0.045% ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.